Yemen Health Report
SEE OTHER BRANDS

The best news from Yemen on health and wellness

Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on August 5, 2025

Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025

Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025

SCOTTSDALE, Ariz., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug …

Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne

Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne

Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne Year-over-year Q2 revenues increased by 20% to $26.6 million Adjusted EBITDA …

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …

OrthoPediatrics Corp. Announces Continued Expansion of Specialty Bracing Division Into New Territories with Multiple Clinics

OrthoPediatrics Corp. Announces Continued Expansion of Specialty Bracing Division Into New Territories with Multiple Clinics

WARSAW, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics …

Ultragenyx Reports Second Quarter 2025 Financial Results and Corporate Update

Ultragenyx Reports Second Quarter 2025 Financial Results and Corporate Update

Second quarter total revenue of $166 million, Crysvita® revenue of $120 million and Dojolvi® revenue of $23 million Reaffirm 2025 Revenue Guidance: Total revenue between $640 million to $670 million, Crysvita revenue of $460 million to $480 million, and …

Jushi Holdings Inc. Reports Second Quarter 2025 Financial Results

Jushi Holdings Inc. Reports Second Quarter 2025 Financial Results

Revenue of $65.0 million, Reflecting Year-over-Year and Sequential Growth Net Loss of $12.3 million, Compared to $17.0 million in the First Quarter of 2025 Adjusted EBITDA Increased 39.6% Quarter-over-Quarter to $13.7 million, Up From $9.8 million in Q1 …

Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025

Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025

NEWTON, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the …

Day One Reports Second Quarter 2025 Financial Results and Corporate Progress

Day One Reports Second Quarter 2025 Financial Results and Corporate Progress

OJEMDA™ (tovorafenib) net product revenue of $33.6 million in Q2 2025, a 10% quarter-over-quarter increase OJEMDA full-year 2025 net product revenue expected to be $140 to $150 million Ended the second quarter with $453.1 million in cash, cash equivalents …

Pacira BioSciences Reports Second Quarter 2025 Financial Results

Pacira BioSciences Reports Second Quarter 2025 Financial Results

-- Solid execution across corporate, clinical and commercial initiatives -- -- Several key milestones advance 5x30 path to growth -- -- Conference call today at 4:30 p.m. ET -- BRISBANE, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. ( …

Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology

Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology

Tevogen.AI to explore external market opportunities as a potential revenue source. Beta version to incorporate oncology targets, enhancing the accuracy and diversity of the PredicTcell model and potentially accelerating cancer immunotherapy development. …

PBGH Announces Aurora Chen as Vice President of Advisory Services

PBGH Announces Aurora Chen as Vice President of Advisory Services

Oakland, California, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Purchaser Business Group on Health (PBGH), a nonprofit coalition representing 40 private employers and public entities across the U.S., announces strategic human capital leader, health advisor and …

AAV for the Hereditary Retinal Diseases Clinical Trial Pipeline Analysis Demonstrates 70+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

AAV for the Hereditary Retinal Diseases Clinical Trial Pipeline Analysis Demonstrates 70+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

New York, USA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- AAV for the Hereditary Retinal Diseases Clinical Trial Pipeline Analysis Demonstrates 70+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight  Adeno-associated …

ACGME Names Paige E. Manz, MBA, as Chief of Staff

ACGME Names Paige E. Manz, MBA, as Chief of Staff

Chicago, IL, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The ACGME is pleased to introduce Paige E. Manz, MBA as its new Chief of Staff, effective today, and following a national search. As a member of the Executive Leadership Team, Paige will report to ACGME …

Channel Medsystems Appoints Nelson Whistance as CEO to Lead Next Phase of Growth

Channel Medsystems Appoints Nelson Whistance as CEO to Lead Next Phase of Growth

BERKELEY, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Channel Medsystems, the medical device company that successfully launched the innovative Cerene® technology for endometrial cryotherapy, announced today the appointment of Nelson Whistance as President …

Elegantly Healthy Announces New Book “Being Healthy,” Plus Companion Livestream Series and Online Course

Elegantly Healthy Announces New Book “Being Healthy,” Plus Companion Livestream Series and Online Course

Los Angeles, CA , Aug. 05, 2025 (GLOBE NEWSWIRE) -- Elegantly Healthy, a wellness and lifestyle brand dedicated to mindful living and natural healing, today announced the release of a new book titled Being Healthy, authored by renowned wellness expert …

Rpharmy to Showcase Healthcare System’s Hazardous Drug Risk Initiative at Florida Society of Health System Pharmacists Annual Meeting

Rpharmy to Showcase Healthcare System’s Hazardous Drug Risk Initiative at Florida Society of Health System Pharmacists Annual Meeting

AUSTIN, Texas, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Rpharmy, a leading provider of medical formulary management and hazardous drug safety information software solutions, today announced that the company is a Breakfast Symposium Sponsor at the Florida Society …

Sienna Announces Confirmation of DBRS Credit Rating

Sienna Announces Confirmation of DBRS Credit Rating

MARKHAM, Ontario, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced the confirmation by Dominion Bond Rating Service (“DBRS”) of the Company’s BBB Issuer Rating and ratings on its Senior Unsecured …

HMNC Brain Health Announces Phase 2 Results from OLIVE Trial in Major Depressive Disorder (MDD) with Genetically Guided Precision Approach

HMNC Brain Health Announces Phase 2 Results from OLIVE Trial in Major Depressive Disorder (MDD) with Genetically Guided Precision Approach

BH-200 (nelivaptan) achieved clinically meaningful reduction in depressive symptoms across the full study population (Difference between BH-200 and placebo in HAM-D17 change from baseline at Week 8: -2.98; p = 0.0003) The largest and most rapid improvement …

Report: The Average Starting Salary for Physicians Exceeds $400,000

Report: The Average Starting Salary for Physicians Exceeds $400,000

DALLAS, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The average starting salary for physicians is $403,000, with orthopedic surgeons at the high end of the starting salary scale at $576,000 and pediatricians at the low end at $258,000, according to an annual report …

Zarminali Pediatrics Expands Clinical Leadership with Chief Medical Officer, Continues Network Growth Throughout United States

Zarminali Pediatrics Expands Clinical Leadership with Chief Medical Officer, Continues Network Growth Throughout United States

CHICAGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Zarminali Pediatrics, the first outpatient pediatric destination purpose-built to provide elevated, seamlessly coordinated primary and specialty care nationwide, announced the hiring of Amanda Furr, MD, as Chief …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions